Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)

​ Conditions: Respiratory Recurrent Papillomatosis (RRP); Human Papillomavirus (HPV); Papillomavirus Infection; Laryngeal Diseases; Tracheal Diseases; Respiratory Tract Neoplasm

Interventions: Drug: PRGN-2012; Drug: Bevacizumab

Sponsors: National Cancer Institute (NCI)

Not yet recruiting Conditions: Respiratory Recurrent Papillomatosis (RRP); Human Papillomavirus (HPV); Papillomavirus Infection; Laryngeal Diseases; Tracheal Diseases; Respiratory Tract Neoplasm
Interventions: Drug: PRGN-2012; Drug: Bevacizumab
Sponsors: National Cancer Institute (NCI)
Not yet recruiting